Cell No. : Cell Name TDC0009 : PDT-EAC#5  update : 2025/06/17
Comment			Currently not ready. Tumor organoid.
Comment from the depositor			Tumoroids derived from a patient with esophageal adenocarcinoma. The tumoroids carried a biallelic TP53 mutation (c. 406C>T, p. Q136*) and ERBB2 amplification.
Terms and conditions
Remarks
Order Form
			Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
	Basic information	Expected time	Upon a request we will start preparation. Contact us: cellkitaku.brc@riken.jp
		IPR	Kawasaki Medical School
		Depositor	FUKAZAWA, Takuya
		Originator	FUKAZAWA, Takuya
Reference information		Reference	1
		User's Publication	0

Top

Reference

22964  Urano T, Yokota E, Iwai M, Yukawa T, Naomoto Y, Takigawa N, Fujiwara H, Akiyama T, Haisa M, Fukazawa T, Yamatsuji T.  Establishment and characterization of novel patient-derived esophageal tumoroids with long-term cultivability  Hum Cell  2025  38(3):72  PubMed ID: 40108093   DOI: 10.1007/s13577-025-01206-x

Top

User's Publication